BREAKING
Albertsons Companies, Inc. Q4 Disappoints: EPS 29.4% Below Estimates 2 minutes ago Bank7 Corp. Tops Q1 Forecasts With EPS, 20.2% Above Consensus 59 minutes ago SemiLEDs Corporation Sinks 5.5% as Stock Drops 5% 1 hour ago TH International Stock Rallies 6.4% After Q4 Earnings Release 1 hour ago FB Financial Corporation (FBK) Posts Q1 2026 Results 2 hours ago Creative Realities, Inc. Stock Rallies 6.1% as Q4 Stock Surges 6% 2 hours ago CarMax Stock Jumps 5% After Q4 Adj. Earnings Beat 2 hours ago Wells Fargo (WFC) Q1 2026 Earnings: Key financials and quarterly highlights 2 hours ago Key highlights from JPMorgan’s (JPM) Q1 2026 earnings results 3 hours ago Johnson & Johnson (JNJ) Earnings: 1Q26 Key Numbers 3 hours ago Albertsons Companies, Inc. Q4 Disappoints: EPS 29.4% Below Estimates 2 minutes ago Bank7 Corp. Tops Q1 Forecasts With EPS, 20.2% Above Consensus 59 minutes ago SemiLEDs Corporation Sinks 5.5% as Stock Drops 5% 1 hour ago TH International Stock Rallies 6.4% After Q4 Earnings Release 1 hour ago FB Financial Corporation (FBK) Posts Q1 2026 Results 2 hours ago Creative Realities, Inc. Stock Rallies 6.1% as Q4 Stock Surges 6% 2 hours ago CarMax Stock Jumps 5% After Q4 Adj. Earnings Beat 2 hours ago Wells Fargo (WFC) Q1 2026 Earnings: Key financials and quarterly highlights 2 hours ago Key highlights from JPMorgan’s (JPM) Q1 2026 earnings results 3 hours ago Johnson & Johnson (JNJ) Earnings: 1Q26 Key Numbers 3 hours ago
ADVERTISEMENT
NBIX

Neurocrine Biosciences, Inc

$NBIX NASDAQ Apr 14, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

NBIX Coverage

Event Neurocrine Biosciences, Inc (NBIX) Sec Form 8K Apr 7, 2026 Event Neurocrine Biosciences, Inc (NBIX) Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio Apr 6, 2026 Event Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings Mar 26, 2026 Transcript Neurocrine Biosciences, Inc (NBIX) Q4 2025 Earnings Call Transcript Mar 10, 2026 Transcript Neurocrine Biosciences, Inc (NBIX) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Neurocrine Biosciences, Inc (NBIX) Q3 2025 Earnings Call Transcript Jan 22, 2026